Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)

Introduction Since 2014, Balloon Pulmonary Angioplasty (BPA) has become an emerging and complementary strategy for chronic thromboembolic hypertension (CTEPH) patients who are not suitable for pulmonary endarterectomy (PEA) or who have recurrent symptoms after the PEA procedure. Objective To assess the hospital cost of BPA sessions and management in CTEPH patients. Methods An observational retrospective cohort study of CTEPH-adults hospitalized for a BPA between January 1st, 2014 and June 30th, 2016 was conducted in the 2 centres performing BPA in France (Paris Sud and Grenoble) using the French national hospital discharge database (PMSI-MCO). Patients were followed until 6 months or death, whichever occurred first. Follow-up stays were classified as stays with BPA sessions, for BPA management or for CTEPH management based on a pre-defined algorithm and a medical review using type of diagnosis (ICD-10), delay from last BPA procedure stay and length of stay. Hospital costs (including medical transports) were estimated from National Health Insurance perspective using published official French tariffs from 2014 to 2016 and expressed in 2017 Euros. Results A total of 191 patients were analysed; mainly male (53%), with a mean age of 64,3 years. The first BPA session was performed 1.1 years in median (IQR 0.3–2.92) after the first PH hospitalisation. A mean of 3 stays with BPA sessions per patient were reported with a mean length of stay of 8 days for the first stay and 6 days for successive stays. The total hospital cost attributable to BPA was € 4,057,825 corresponding to €8,764±3,435 per stay and €21,245±12,843 per patient. Results were sensitive to age classes, density of commune of residence and some comorbidities. Conclusions The study generated robust real-world data to assess the hospital cost of BPA sessions and management in CTEPH patients within its first years of implementation in France.

Download Full-text

PCV25 Hospital Costs of Balloon Pulmonary Angioplasty (BPA) Procedure and Management for Chronic Thromboembolic Hypertension Patients: An Observational Study Based on the French National Hospital Discharge Database (PMSI)

Value in Health ◽

10.1016/j.jval.2020.08.516 ◽

2020 ◽

Vol 23 ◽

pp. S491

Author(s):

V. Cottin ◽

L. Bensimon ◽

F. Raguideau ◽

G. Chaize ◽

A. Hakmé ◽

...

Keyword(s):

Observational Study ◽

Hospital Discharge ◽

Hospital Costs ◽

National Hospital ◽

Hospital Discharge Database ◽

Balloon Pulmonary Angioplasty ◽

Discharge Database

Download Full-text

Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database

European Journal of Epidemiology ◽

10.1007/s10654-007-9158-6 ◽

2007 ◽

Vol 22 (9) ◽

pp. 607-614 ◽

Cited By ~ 20

Author(s):

Zoe Uhry ◽

Marc Colonna ◽

Laurent Remontet ◽

Pascale Grosclaude ◽

Nicolas Carré ◽

...

Keyword(s):

Thyroid Cancer ◽

Hospital Discharge ◽

Cancer Incidence ◽

Cancer Registries ◽

National Hospital ◽

Hospital Discharge Database ◽

Thyroid Cancer Incidence ◽

Discharge Database

Download Full-text

Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the Spanish National Hospital Discharge Database, 2013–2014

BMJ Open ◽

10.1136/bmjopen-2017-017676 ◽

2017 ◽

Vol 7 (11) ◽

pp. e017676 ◽

Cited By ~ 2

Author(s):

Ana Lopez-de-Andres ◽

Isabel Jimenez-Trujillo ◽

Valentin Hernandez-Barrera ◽

Javier de Miguel-Diez ◽

Manuel Mendez-Bailon ◽

...

Keyword(s):

Breast Cancer ◽

Type 2 Diabetes ◽

Retrospective Study ◽

Hospital Discharge ◽

Surgical Procedures ◽

Surgical Procedure ◽

National Hospital ◽

Hospital Discharge Database ◽

Discharge Database

ObjectivesTo compare the type of surgical procedures used, comorbidities, in-hospital complications (IHC) and in-hospital outcomes between women with type 2 diabetes mellitus (T2DM) and age-matched women without diabetes who were hospitalised with breast cancer. In addition, we sought to identify factors associated with IHC in women with T2DM who had undergone surgical procedures for breast cancer.DesignRetrospective study using the National Hospital Discharge Database, 2013–2014.SettingSpain.ParticipantsWomen who were aged ≥40 years with a primary diagnosis of breast cancer and who had undergone a surgical procedure. We grouped admissions by T2DM status. We selected one matched control for each T2DM case.Main outcome measuresThe type of procedure (breast-conserving surgery (BCS) or mastectomy), clinical characteristics, complications, length of hospital stay and in-hospital mortality.ResultsWe identified 41 458 admissions (9.23% with T2DM). Overall, and in addition to the surgical procedure, we found that comorbidity, hypertension and obesity were more common among patients with T2DM. We also detected a higher incidence of mastectomy in women with T2DM (44.69% vs 42.42%) and a greater rate of BCS in patients without T2DM (57.58% vs 55.31%). Overall, non-infectious complications were more common among women with T2DM (6.40% vs 4.56%). Among women who had undergone BCS or a mastectomy, IHC were more frequent among diabetics (5.57% vs 3.04% and 10.60% vs 8.24%, respectively). Comorbidity was significantly associated with a higher risk of IHC in women with diabetes, independent of the specific procedure used.provinceConclusionsWomen with T2DM who undergo surgical breast cancer procedures have more comorbidity, risk factors and advanced cancer presentations than matched patients without T2DM. Mastectomies are more common in women with T2DM. Moreover, the procedures among women with T2DM were associated with greater IHC. Comorbidity was a strong predictor of IHC in women with T2DM.

Download Full-text